+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cancer Tumor Profiling Global Market Report 2024

  • PDF Icon

    Report

  • 200 Pages
  • December 2023
  • Region: Global
  • The Business Research Company
  • ID: 5744161

Quick Summary:

In the rapidly growing field of personalized healthcare, the global cancer tumor profiling market holds significant potential. This sophisticated technology, that involves detailed examination of tumor tissues to identify specific genes, proteins, or other markers is increasingly being recognized as a game changer by healthcare professionals worldwide. Comprehensive understanding of individual tumor profiles is rapidly proving fundamental in planning effective treatment strategies and predicting the disease patterns for cancer patients.

Largely driven by an increase in global incidence of cancer, this market is poised on the brink of exponential growth. Cancer tumor profiling's unique ability to aid precision in diagnostics, prognosis and research applications has fueled this high demand. In addition to this, the market is witnessing growing investment in research and development activities by leading players seeking assertive positioning in this field. Leveraging cancer tumor profiling, oncologists can better determine the severity of the disease, contributing towards improved treatment outcomes.

This market report provides detailed and invaluable insights into the ever-evolving cancer tumor profiling market. It offers a deep-dive into the global market size and regional shares, along with a comprehensive competitor analysis. Armed with these insights, you can make informed strategic decisions to leverage the opportunities within the cancer tumor profiling industry, ensuring business growth and success.

Cancer tumor profiling is a laboratory testing method designed to analyze a sample of tumor tissue for specific genes, gene mutations, proteins, or other biomarkers. This comprehensive examination aids in treatment planning and provides valuable insights into the likelihood of cancer recurrence or metastasis.

The primary categories of cancer and tumor profiling encompass lung cancer, breast cancer, colorectal cancer, prostate cancer, melanoma, ovarian cancer, stomach cancer, pancreatic cancer, thyroid cancer, and various other cancer types. Diverse technologies, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH), microarrays, and others, are employed in this process. These technologies cover multiple facets, including genomics, proteomics, epigenetics, metabolomics, and more. Cancer and tumor profiling find applications in personalized medicine, diagnostics, biomarker discovery, prognostics, and research endeavors.

The cancer tumor profiling market research report is one of a series of new reports that provides cancer tumor profiling market statistics, including cancer tumor profiling industry global market size, regional shares, competitors with a cancer tumor profiling market share, detailed cancer tumor profiling market segments, market trends and opportunities, and any further data you may need to thrive in the cancer tumor profiling industry. This cancer tumor profiling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer tumor profiling market size has grown rapidly in recent years. It will grow from $11.17 billion in 2023 to $12.93 billion in 2024 at a compound annual growth rate (CAGR) of 15.7%. The historical growth in cancer tumor profiling can be attributed to factors such as the rising incidence of cancer, the expansion of precision medicine initiatives and collaborative research efforts, advancements in cancer diagnostics and early detection methodologies, the availability of a diverse array of targeted therapy options, and supportive regulatory frameworks facilitating cancer profiling tests.

The cancer tumor profiling market size is expected to see rapid growth in the next few years. It will grow to $22.06 billion in 2028 at a compound annual growth rate (CAGR) of 14.3%. The forecasted growth in cancer tumor profiling is anticipated due to the expanding applications of immunotherapy and immunoprofiling in cancer treatment, the development of liquid biopsy and non-invasive tumor profiling methods, the adoption of single-cell sequencing for more detailed tumor characterization, the extension of cancer screening and early detection programs, and the increasing demand for profiling rare and orphan cancer subtypes. Noteworthy trends in the forecast period include the integration of tumor profiling into routine clinical practice, advancements in multi-omics approaches, the incorporation of artificial intelligence (AI) and machine learning in data analysis, the development of personalized medicine and targeted therapy, and progress in genomics and next-generation sequencing (NGS) technologies.

The surge in cancer cases worldwide is expected to drive the growth of the cancer and tumor profiling market. Cancer, characterized by uncontrolled cell growth and spreading, necessitates advanced diagnostic tools such as cancer tumor profiling to assess the severity of the disease. In 2021, the American Cancer Society reported 1.8 million new cancer cases diagnosed in 2020, underscoring the increasing prevalence of cancer globally. The rising incidences of cancer contribute significantly to the expansion of the cancer and tumor profiling market.

The increasing prevalence of stomach cancer is anticipated to be a key driver for the growth of the cancer and tumor profiling market. Stomach cancer involves the uncontrolled growth of malignant cells in the stomach lining, and cancer and tumor profiling play a crucial role in providing insights into the development of this disease. For example, gastrointestinal stromal tumors (GISTs), though distinct from stomach cancer, can occur in the stomach, and cancer and tumor profiling can help in understanding and treating such cases. As indicated by Cancer Research UK, the incidence of stomach cancer in the UK is expected to decline by 12% between 2023-2025 and 2038-2040. This decline, while positive, highlights the need for continued focus on stomach cancer research and tumor profiling to further address the disease. The growing prevalence of stomach cancer is thus contributing to the expansion of the cancer and tumor profiling market.

Increasing research and development activities are emerging as a significant trend in the cancer and tumor profiling market. Major companies in this sector are prioritizing research and development to meet consumer demands and strengthen their market position. For instance, QIAGEN N.V, a German company specializing in sample and assay technology, recently announced the Conformitè Europëenne (CE)-marking and commercialization of the therascreen PIK3CA RGQ PCR Kit in Europe. This diagnostic assay is designed to identify breast cancer patients with PIK3CA mutations, providing crucial information for personalized treatment. The emphasis on research and development activities is a notable trend that is shaping the cancer and tumor profiling market.

In June 2023, Quest Diagnostics, a prominent US-based medical laboratory company, completed the acquisition of Haystack Oncology Inc. for a substantial sum of $450 million. The strategic move by Quest Diagnostics is aimed at broadening access to liquid biopsy technology and strengthening its position in the competitive field of cancer diagnostics. This acquisition is anticipated to augment Quest Diagnostics' research and development capabilities, thereby enhancing its ability to contribute to improved outcomes for cancer patients. Haystack Oncology Inc., based in the United States, is an early-stage oncology company specializing in the development of solid tumor testing technology.

In July 2021, Labcorp, another major US-based clinical laboratory, successfully acquired OmniSeq for an undisclosed amount. This strategic acquisition provides Labcorp with an expanded portfolio of clinical trial options and diagnostic tests tailored for cancer patients and healthcare providers. OmniSeq, a US-based company with expertise in solid tumor profiling, possesses innovative sequencing technologies and actively supports drug development through its pharmaceutical services. This acquisition positions Labcorp to play a more significant role in advancing cancer diagnostics and contributing to the ongoing development of therapeutic solutions.

Major companies operating in the cancer tumor profiling market include F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., Qiagen, Ribomed Biotechnologies Inc., HTG Molecular Diagnostics Inc., NanoString Technologies Inc., NeoGenomics Laboratories Inc., Lucence Health Inc., ACT Genomics Co. Ltd., Strand Life Sciences, IMB Dx Inc., Exact Sciences Corporation, Guardant Health, Foundation Medicine Inc., Agilent Technologies Inc., Myriad Genetics Inc., Personal Genome Diagnostics Inc., Tempus Labs Inc., ArcherDX Inc., Natera Inc., Bio-Rad Laboratories Inc., Genetron Health, NantHealth Inc., Resolution Bioscience, Genomic Testing Cooperative, OncoDNA, Strata Oncology Inc., Genuity Science, RareCyte Inc., Inivata Limited, Cepheid

North America was the largest region in cancer and tumor profiling market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cancer and tumor profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the cancer tumor profiling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The cancer tumor profiling market includes revenues earned by entities by sanger sequencing, pyro sequencing (PyroSeq), chromogenic/ fluorescence in situ hybridization (CISH/FISH) and fragment analysis (FA/Frag. Analysis). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Cancer Tumor Profiling Market Characteristics3. Cancer Tumor Profiling Market Trends And Strategies
4. Cancer Tumor Profiling Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Cancer Tumor Profiling Market Size and Growth
5.1. Global Cancer Tumor Profiling Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Cancer Tumor Profiling Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Cancer Tumor Profiling Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Cancer Tumor Profiling Market Segmentation
6.1. Global Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Melanoma
Ovarian Cancer
Stomach Cancer
Pancreatic Cancer
Thyroid Cancer
Other Cancer Types
6.2. Global Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Other Technologies
6.3. Global Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
7. Cancer Tumor Profiling Market Regional And Country Analysis
7.1. Global Cancer Tumor Profiling Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cancer Tumor Profiling Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Cancer Tumor Profiling Market
8.1. Asia-Pacific Cancer Tumor Profiling Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Cancer Tumor Profiling Market
9.1. China Cancer Tumor Profiling Market Overview
9.2. China Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Cancer Tumor Profiling Market
10.1. India Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Cancer Tumor Profiling Market
11.1. Japan Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Cancer Tumor Profiling Market
12.1. Australia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Cancer Tumor Profiling Market
13.1. Indonesia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Cancer Tumor Profiling Market
14.1. South Korea Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Cancer Tumor Profiling Market
15.1. Western Europe Cancer Tumor Profiling Market Overview
15.2. Western Europe Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Cancer Tumor Profiling Market
16.1. UK Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Cancer Tumor Profiling Market
17.1. Germany Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Cancer Tumor Profiling Market
18.5. France Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Cancer Tumor Profiling Market
19.9. Italy Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Cancer Tumor Profiling Market
20.13. Spain Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Cancer Tumor Profiling Market
21.1. Eastern Europe Cancer Tumor Profiling Market Overview
21.2. Eastern Europe Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Cancer Tumor Profiling Market
22.1. Russia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Cancer Tumor Profiling Market
23.1. North America Cancer Tumor Profiling Market Overview
23.2. North America Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Cancer Tumor Profiling Market
24.1. USA Cancer Tumor Profiling Market Overview
24.2. USA Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Cancer Tumor Profiling Market
25.1. Canada Cancer Tumor Profiling Market Overview
25.2. Canada Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Cancer Tumor Profiling Market
26.1. South America Cancer Tumor Profiling Market Overview
26.2. South America Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Cancer Tumor Profiling Market
27.1. Brazil Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Cancer Tumor Profiling Market
28.1. Middle East Cancer Tumor Profiling Market Overview
28.2. Middle East Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Cancer Tumor Profiling Market
29.1. Africa Cancer Tumor Profiling Market Overview
29.2. Africa Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cancer Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Cancer Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Cancer Tumor Profiling Market Competitive Landscape And Company Profiles
30.1. Cancer Tumor Profiling Market Competitive Landscape
30.2. Cancer Tumor Profiling Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Caris Life Sciences
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Thermo Fisher Scientific Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Illumina Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Qiagen
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Global Cancer Tumor Profiling Market Competitive Benchmarking32. Global Cancer Tumor Profiling Market Competitive Dashboard33. Key Mergers And Acquisitions In The Cancer Tumor Profiling Market
34. Cancer Tumor Profiling Market Future Outlook and Potential Analysis
34.1 Cancer Tumor Profiling Market In 2028 - Countries Offering Most New Opportunities
34.2 Cancer Tumor Profiling Market In 2028 - Segments Offering Most New Opportunities
34.3 Cancer Tumor Profiling Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

Executive Summary

Cancer Tumor Profiling Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer tumor profiling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for cancer tumor profiling? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

  • Markets Covered: 1) By Cancer Type: Lung Cancer; Breast Cancer; Colorectal Cancer; Prostate Cancer; Melanoma; Ovarian Cancer; Stomach Cancer; Pancreatic Cancer; Thyroid Cancer; Other Cancer Types 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Immunohistochemistry (IHC); In Situ Hybridization (ISH); Microarray; Other Technologies 3) By Process Type: Genomics; Proteomics; Epigenetics; Metabolomics; Other Types 4) By Application: Personalized Medicine; Diagnostics; Biomarker Discovery; Prognostics; Research Applications
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Caris Life Sciences; Thermo Fisher Scientific Inc.; Illumina Inc.; Qiagen
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • F. Hoffmann-La Roche Ltd.
  • Caris Life Sciences
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Qiagen
  • Ribomed Biotechnologies Inc.
  • HTG Molecular Diagnostics Inc.
  • NanoString Technologies Inc.
  • NeoGenomics Laboratories Inc.
  • Lucence Health Inc.
  • ACT Genomics Co. LTD
  • Strand Life Sciences
  • IMB Dx Inc.
  • Exact Sciences Corporation
  • Guardant Health
  • Foundation Medicine Inc.
  • Agilent Technologies Inc.
  • Myriad Genetics Inc.
  • Personal Genome Diagnostics Inc.
  • Tempus Labs Inc.
  • ArcherDX Inc.
  • Natera Inc.
  • Bio-Rad Laboratories Inc.
  • Genetron Health
  • NantHealth Inc.
  • Resolution Bioscience
  • Genomic Testing Cooperative
  • OncoDNA
  • Strata Oncology Inc.
  • Genuity Science
  • RareCyte Inc.
  • Inivata Limited
  • Cepheid

Methodology

Loading
LOADING...